These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6306544)

  • 1. New Haemophilus influenzae type b control strategy: premature commitment to prophylaxis?
    Mann JM; Hull HF
    Pediatrics; 1983 Jul; 72(1):118-21. PubMed ID: 6306544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease.
    Murphy TV; Clements JF; Breedlove JA; Hansen EJ; Seibert GB
    N Engl J Med; 1987 Jan; 316(1):5-10. PubMed ID: 3491319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease.
    Gessert C; Granoff DM; Gilsdorf J
    Pediatrics; 1980 Jul; 66(1):1-4. PubMed ID: 6967580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update: prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(11):170-4, 179-80. PubMed ID: 3081787
    [No Abstract]   [Full Text] [Related]  

  • 7. Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin.
    Yogev R; Melick C; Kabat K
    Pediatrics; 1981 Mar; 67(3):430-3. PubMed ID: 6972517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of contacts of children in day care with invasive Haemophilus influenzae type b disease.
    Dashefsky B; Wald E; Li K
    Pediatrics; 1986 Nov; 78(5):939-41. PubMed ID: 3489921
    [No Abstract]   [Full Text] [Related]  

  • 9. Haemophilus influenzae type b colonization in household contacts of infected and colonized children enrolled in day care.
    Li KI; Dashefsky B; Wald ER
    Pediatrics; 1986 Jul; 78(1):15-20. PubMed ID: 3487771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae type b in a nursery school: the value of biotyping.
    Prober CG; Ipp MM; Bannatyne RM
    Pediatrics; 1982 Feb; 69(2):215-8. PubMed ID: 6977129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. American Academy of Pediatrics Committee on Infectious Diseases: Revision of recommendation for use of rifampin prophylaxis of contacts of patients with Haemophilus influenzae infection.
    Pediatrics; 1984 Aug; 74(2):301-2. PubMed ID: 6379591
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More on rifampin prophylaxis against Haemophilus influenzae b in day-care facilities.
    Broome CV; Mortimer EA; Katz SL; Fleming DW; Hightower AW
    N Engl J Med; 1988 Jan; 318(1):48-9. PubMed ID: 3257291
    [No Abstract]   [Full Text] [Related]  

  • 14. Counterpoint: the red book opts for red urine.
    Daum RS; Halsey NA
    Pediatr Infect Dis; 1982; 1(6):378-81. PubMed ID: 6819550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin prophylaxis against Haemophilus influenzae type B.
    Keller DM
    N Engl J Med; 1987 Nov; 317(19):1225. PubMed ID: 3498899
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin.
    Granoff DM; Gilsdorf J; Gessert C; Basden M
    Pediatrics; 1979 Mar; 63(3):397-401. PubMed ID: 312483
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemophilus influenzae type b disease after rifampin prophylaxis in a day care center: possible reasons for its failure.
    Murphy TV; McCracken GH; Moore BS; Gulig PA; Hansen EJ
    Pediatr Infect Dis; 1983; 2(3):193-8. PubMed ID: 6602974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of secondary cases of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Dec; 31(50):672-4, 679-80. PubMed ID: 6819447
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenge of ongoing Haemophilus influenzae type B carriage and transmission in Alaska.
    Lucher LA; Singleton R; Parkinson AJ; Butler JC
    Alaska Med; 1999; 41(3):61-8. PubMed ID: 10540498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.